Landscape of cancer diagnostic biomarkers from specifically expressed genes
Authors:
- 1 December 2019
- journal article
- research article
- Published by Oxford University Press (OUP) in Briefings in Bioinformatics
- Vol. 21 (6) , 2175-2184
Abstract
Although there has been great progress in cancer treatment, cancer remains a serious health threat to humans because of the lack of biomarkers for diagnosis, especially for early-stage diagnosis. In this study, we comprehensively surveyed the specifically expressed genes (SEGs) using the SEGtool based on the big data of gene expression from the The Cancer Genome Atlas (TCGA) and the Genotype–Tissue Expression (GTEx) projects. In 15 solid tumors, we identified 233 cancer-specific SEGs (cSEGs), which were specifically expressed in only one cancer and showed great potential to be diagnostic biomarkers. Among them, three cSEGs (OGDH, MUDENG and ACO2) had a sample frequency >80% in kidney cancer, suggesting their high sensitivity. Furthermore, we identified 254 cSEGs as early-stage diagnostic biomarkers across 17 cancers. A two-gene combination strategy was applied to improve the sensitivity of diagnostic biomarkers, and hundreds of two-gene combinations were identified with high frequency. We also observed that 13 SEGs were targets of various drugs and nearly half of these drugs may be repurposed to treat cancers with SEGs as their targets. Several SEGs were regulated by specific transcription factors in the corresponding cancer, and 39 cSEGs were prognosis-related genes in 7 cancers. This work provides a survey of cancer biomarkers for diagnosis and early diagnosis and new insights to drug repurposing. These biomarkers may have great potential in cancer research and application.Keywords
Funding Information
- National Natural Science Foundation of China (31822030, 31771458, 31801113)
- China Postdoctoral Science Foundation (2018 M632830)
This publication has 42 references indexed in Scilit:
- The Cancer Genome Atlas Pan-Cancer analysis projectNature Genetics, 2013
- Publication of Tumor Marker Research Results: The Necessity for Complete and Transparent ReportingJournal of Clinical Oncology, 2012
- Tissue-Specific Cadherin CDH17 Is a Useful Marker of Gastrointestinal Adenocarcinomas With Higher Sensitivity Than CDX2American Journal of Clinical Pathology, 2012
- Whole-genome sequencing of liver cancers identifies etiological influences on mutation patterns and recurrent mutations in chromatin regulatorsNature Genetics, 2012
- BRCA1 and GATA3 corepress FOXC1 to inhibit the pathogenesis of basal-like breast cancersOncogene, 2011
- HOMER: a human organ-specific molecular electronic repositoryBMC Bioinformatics, 2011
- Tissue-specific disallowance of housekeeping genes: The other face of cell differentiationGenome Research, 2010
- Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancerInternational Journal of Cancer, 2010
- A large-scale analysis of tissue-specific pathology and gene expression of human disease genes and complexesProceedings of the National Academy of Sciences, 2008
- Phase II trial of subcutaneous anti-CD52 monoclonal antibody alemtuzumab (Campath-1H) as first-line treatment for patients with B-cell chronic lymphocytic leukemia (B-CLL)Blood, 2002